25 XP   0   0   10

Adicet Bio Inc
Buy, Hold or Sell?

Let's analyse Adicet Bio Inc together

PenkeI guess you are interested in Adicet Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Adicet Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Adicet Bio Inc

I send you an email if I find something interesting about Adicet Bio Inc.

Quick analysis of Adicet Bio Inc (30 sec.)










What can you expect buying and holding a share of Adicet Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
52.5%

What is your share worth?

Current worth
$2.07
Expected worth in 1 year
$0.58
How sure are you?
57.5%

+ What do you gain per year?

Total Gains per Share
$-1.49
Return On Investment
-70.8%

For what price can you sell your share?

Current Price per Share
$2.10
Expected price per share
$1.69 - $3.59
How sure are you?
50%

1. Valuation of Adicet Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$2.10

Intrinsic Value Per Share

$-12.45 - $-8.45

Total Value Per Share

$-10.38 - $-6.38

2. Growth of Adicet Bio Inc (5 min.)




Is Adicet Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$170.1m$303.5m-$86m-39.6%

How much money is Adicet Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$35.3m-$16.7m-$18.6m-52.7%
Net Profit Margin0.0%32.7%--

How much money comes from the company's main activities?

3. Financial Health of Adicet Bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#275 / 1010

Most Revenue
#902 / 1010

Most Profit
#831 / 1010

Most Efficient
#343 / 1010

What can you expect buying and holding a share of Adicet Bio Inc? (5 min.)

Welcome investor! Adicet Bio Inc's management wants to use your money to grow the business. In return you get a share of Adicet Bio Inc.

What can you expect buying and holding a share of Adicet Bio Inc?

First you should know what it really means to hold a share of Adicet Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Adicet Bio Inc is $2.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Adicet Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Adicet Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.07. Based on the TTM, the Book Value Change Per Share is $-0.37 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Adicet Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.36-17.1%-0.44-20.9%-0.21-10.1%-0.21-9.9%-0.18-8.8%
Usd Book Value Change Per Share-0.30-14.2%-0.37-17.7%-0.03-1.6%0.104.9%-0.01-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.010.6%
Usd Total Gains Per Share-0.30-14.2%-0.37-17.7%-0.03-1.6%0.115.1%0.00-0.1%
Usd Price Per Share1.89-2.86-14.43-8.72-5.42-
Price to Earnings Ratio-1.32--1.77-14.02--10.29--26.53-
Price-to-Total Gains Ratio-6.34--8.58-39.45--14.70--23.80-
Price to Book Ratio0.91-1.03-3.89-3.66-57.11-
Price-to-Total Gains Ratio-6.34--8.58-39.45--14.70--23.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.1
Number of shares476
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.370.10
Usd Total Gains Per Share-0.370.11
Gains per Quarter (476 shares)-176.9550.69
Gains per Year (476 shares)-707.81202.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-708-7186197193
20-1416-142612394396
30-2123-213418590599
40-2831-284224787802
50-3539-3550309841005
60-4247-42583611811208
70-4955-49664213781411
80-5662-56744815751614
90-6370-63825417711817
100-7078-70905919682020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%15.025.00.037.5%69.027.00.071.9%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%7.013.00.035.0%23.017.00.057.5%68.028.00.070.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%21.00.019.052.5%57.00.039.059.4%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%7.013.00.035.0%23.017.00.057.5%74.022.00.077.1%

Fundamentals of Adicet Bio Inc

About Adicet Bio Inc

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. The company is also developing ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma for treating other CD70+ solid tumor and hematological malignancies indications. The company was founded in 2014 and is based in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-10 23:25:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Adicet Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Adicet Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Adicet Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Adicet Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY32.7%-32.7%
TTM-5Y-69.2%+69.2%
5Y-69.2%10Y-32.3%-36.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY32.7%-288.3%+321.0%
5Y-69.2%-449.1%+379.9%
10Y-32.3%-605.5%+573.2%
1.1.2. Return on Assets

Shows how efficient Adicet Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Adicet Bio Inc to the Biotechnology industry mean.
  • -14.2% Return on Assets means that Adicet Bio Inc generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Adicet Bio Inc:

  • The MRQ is -14.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.2%TTM-14.2%+0.0%
TTM-14.2%YOY-5.0%-9.3%
TTM-14.2%5Y-8.6%-5.6%
5Y-8.6%10Y-8.9%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.2%-13.3%-0.9%
TTM-14.2%-12.8%-1.4%
YOY-5.0%-11.7%+6.7%
5Y-8.6%-13.9%+5.3%
10Y-8.9%-15.7%+6.8%
1.1.3. Return on Equity

Shows how efficient Adicet Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Adicet Bio Inc to the Biotechnology industry mean.
  • -17.3% Return on Equity means Adicet Bio Inc generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Adicet Bio Inc:

  • The MRQ is -17.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.3%TTM-14.1%-3.2%
TTM-14.1%YOY-3.2%-10.9%
TTM-14.1%5Y-8.2%-5.9%
5Y-8.2%10Y-5.5%-2.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.3%-16.9%-0.4%
TTM-14.1%-16.1%+2.0%
YOY-3.2%-15.1%+11.9%
5Y-8.2%-19.3%+11.1%
10Y-5.5%-20.2%+14.7%

1.2. Operating Efficiency of Adicet Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Adicet Bio Inc is operating .

  • Measures how much profit Adicet Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Adicet Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Adicet Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY36.3%-36.3%
TTM-5Y-74.9%+74.9%
5Y-74.9%10Y-26.0%-49.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY36.3%-298.2%+334.5%
5Y-74.9%-492.1%+417.2%
10Y-26.0%-632.4%+606.4%
1.2.2. Operating Ratio

Measures how efficient Adicet Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Adicet Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.130+0.130
TTM-5Y7.020-7.020
5Y7.02010Y3.883+3.137
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-0.1303.890-4.020
5Y7.0205.739+1.281
10Y3.8837.876-3.993

1.3. Liquidity of Adicet Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Adicet Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.41 means the company has $8.41 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Adicet Bio Inc:

  • The MRQ is 8.414. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.467. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.414TTM10.467-2.054
TTM10.467YOY18.253-7.786
TTM10.4675Y14.142-3.675
5Y14.14210Y9.929+4.213
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.4143.890+4.524
TTM10.4674.173+6.294
YOY18.2535.344+12.909
5Y14.1426.126+8.016
10Y9.9296.448+3.481
1.3.2. Quick Ratio

Measures if Adicet Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Adicet Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.28 means the company can pay off $8.28 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Adicet Bio Inc:

  • The MRQ is 8.281. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.331. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.281TTM10.331-2.050
TTM10.331YOY18.035-7.704
TTM10.3315Y17.099-6.768
5Y17.09910Y16.575+0.524
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2813.514+4.767
TTM10.3313.998+6.333
YOY18.0355.380+12.655
5Y17.0996.105+10.994
10Y16.5756.404+10.171

1.4. Solvency of Adicet Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Adicet Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Adicet Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.18 means that Adicet Bio Inc assets are financed with 17.9% credit (debt) and the remaining percentage (100% - 17.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Adicet Bio Inc:

  • The MRQ is 0.179. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.153. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.179TTM0.153+0.026
TTM0.153YOY0.104+0.048
TTM0.1535Y0.207-0.054
5Y0.20710Y0.300-0.094
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1790.339-0.160
TTM0.1530.336-0.183
YOY0.1040.271-0.167
5Y0.2070.366-0.159
10Y0.3000.389-0.089
1.4.2. Debt to Equity Ratio

Measures if Adicet Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Adicet Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 21.8% means that company has $0.22 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Adicet Bio Inc:

  • The MRQ is 0.218. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.144. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.218TTM0.144+0.074
TTM0.144YOY0.084+0.061
TTM0.1445Y0.123+0.021
5Y0.12310Y0.464-0.341
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2180.388-0.170
TTM0.1440.402-0.258
YOY0.0840.335-0.251
5Y0.1230.426-0.303
10Y0.4640.461+0.003

2. Market Valuation of Adicet Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Adicet Bio Inc generates.

  • Above 15 is considered overpriced but always compare Adicet Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -1.32 means the investor is paying $-1.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Adicet Bio Inc:

  • The EOD is -1.463. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.316. Based on the earnings, the company is expensive. -2
  • The TTM is -1.768. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.463MRQ-1.316-0.146
MRQ-1.316TTM-1.768+0.452
TTM-1.768YOY14.022-15.790
TTM-1.7685Y-10.290+8.523
5Y-10.29010Y-26.532+16.241
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.463-2.264+0.801
MRQ-1.316-2.629+1.313
TTM-1.768-2.680+0.912
YOY14.022-4.145+18.167
5Y-10.290-6.257-4.033
10Y-26.532-6.254-20.278
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Adicet Bio Inc:

  • The EOD is -1.826. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.643. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.338. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.826MRQ-1.643-0.183
MRQ-1.643TTM-2.338+0.695
TTM-2.338YOY59.903-62.242
TTM-2.3385Y1.665-4.003
5Y1.66510Y-0.986+2.650
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.826-2.973+1.147
MRQ-1.643-3.333+1.690
TTM-2.338-3.553+1.215
YOY59.903-5.605+65.508
5Y1.665-8.376+10.041
10Y-0.986-8.865+7.879
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Adicet Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.91 means the investor is paying $0.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Adicet Bio Inc:

  • The EOD is 1.014. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.912. Based on the equity, the company is cheap. +2
  • The TTM is 1.026. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.014MRQ0.912+0.101
MRQ0.912TTM1.026-0.113
TTM1.026YOY3.888-2.863
TTM1.0265Y3.664-2.638
5Y3.66410Y57.105-53.442
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0141.896-0.882
MRQ0.9122.115-1.203
TTM1.0262.093-1.067
YOY3.8882.884+1.004
5Y3.6643.542+0.122
10Y57.1053.916+53.189
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Adicet Bio Inc.

3.1. Institutions holding Adicet Bio Inc

Institutions are holding 67.877% of the shares of Adicet Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Orbimed Advisors, LLC10.12990.3141832214000
2023-12-31RTW INVESTMENTS, LLC5.03280.12214134631-106841-2.519
2023-12-31Morgan Stanley - Brokerage Accounts3.40680.00052798809-1037568-27.0455
2023-12-31COWEN AND COMPANY, LLC3.30510.3366271527800
2023-12-31BlackRock Inc2.65680.00012182675-86803-3.8248
2023-12-31The Carlyle Group Inc2.57490.1913211538500
2023-12-31Vanguard Group Inc2.05110.00011685075126890.7587
2023-12-31Millennium Management LLC1.60870.0011132158742770547.848
2023-09-30TANG CAPITAL MANAGEMENT LLC1.49270.23711226352-1253200-50.5414
2023-12-31Renaissance Technologies Corp0.93310.00227666008960013.2349
2023-12-31Johnson & Johnson0.83820.0297688595-40349-5.5353
2023-12-31Geode Capital Management, LLC0.80560.0001661795288414.5566
2023-12-31State Street Corporation0.77970.000164054370101.1065
2023-12-31Acadian Asset Management LLC0.68130.0041559750367417.0249
2023-12-31Two Sigma Advisers, LLC0.6330.002352003913334334.4826
2023-12-31NORGES BANK0.52290.00014295504295500
2023-12-31Two Sigma Investments LLC0.43910.001636072513540960.0974
2023-09-30Jacobs Levy Equity Management, Inc.0.40610.002733359394372.9113
2023-09-30D. E. Shaw & Co LP0.29810.0004244873213419678.5115
2023-12-31Northern Trust Corp0.28250.000123208516840.7309
Total 38.87841.246431940080-999333-3.1%

3.2. Funds holding Adicet Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.0010.0003164389400
2024-03-28iShares Russell 2000 ETF1.54470.004612690276120.0482
2024-03-28iShares Russell 2000 Value ETF0.60450.0093496647-315-0.0634
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.57180.0011469743358398.2597
2024-01-31Fidelity Small Cap Index0.36920.0037303297173516.0679
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.24190.001119875200
2024-02-29Fidelity Extended Market Index0.22490.0011184735-895-0.4821
2024-03-31A4Investments SICAV SIF ACCI IlanaA2EURH0.2133.64151750001750000
2024-03-28Loncar Cancer Immunotherapy ETF0.18431.23761513842623820.9659
2024-03-31BlackRock Extended Equity Market K0.18280.002415019984758129.5182
2024-03-27Fidelity Enhanced Small Cap ETF0.16540.060813590200
2024-03-28iShares Micro-Cap ETF0.14090.029611579100
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.13610.002711177400
2024-02-29Vanguard Russell 2000 ETF0.13250.002710883385448.5194
2024-01-31TIAA-CREF Equity Index Instl0.13130.000810783800
2024-03-31Russell 2000 Index Non-Lendable Fund E0.11480.0043942994443089.0934
2024-03-31BlackRock Russell 2500™ Index F0.10640.0021873904120189.2009
2023-09-30BlackRock Extended Mkt Composite0.09240.0007759085320.7058
2023-12-31NT R2000 Value Index Fund - NL0.090.003773920-3626-4.6759
2023-12-31NT R2000 Index Fund - NL0.08930.001973396-3499-4.5504
Total 7.33725.0126027729+426170+7.1%

3.3. Insider Transactions

Insiders are holding 1.423% of the shares of Adicet Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-25Orbimed Advisors LlcBUY31250002.4
2023-10-02Chen SchorBUY55001.33
2023-09-28Chen SchorBUY55001.42
2023-06-30Steve DubinBUY50002.4
2023-06-27Carl L GordonBUY8750002.09

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Adicet Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.298-0.372+25%-0.033-89%0.103-389%-0.015-95%
Book Value Per Share--2.0712.648-22%3.695-44%2.288-9%2.623-21%
Current Ratio--8.41410.467-20%18.253-54%14.142-41%9.929-15%
Debt To Asset Ratio--0.1790.153+17%0.104+72%0.207-13%0.300-40%
Debt To Equity Ratio--0.2180.144+51%0.084+161%0.123+77%0.464-53%
Dividend Per Share----0%-0%0.003-100%0.012-100%
Eps---0.359-0.439+22%-0.212-41%-0.207-42%-0.184-49%
Free Cash Flow Per Share---0.288-0.299+4%-0.187-35%-0.182-37%-0.059-80%
Free Cash Flow To Equity Per Share---0.287-0.298+4%-0.061-79%0.020-1559%0.162-277%
Gross Profit Margin--1.0571.014+4%1.000+6%1.003+5%0.982+8%
Intrinsic Value_10Y_max---8.449--------
Intrinsic Value_10Y_min---12.454--------
Intrinsic Value_1Y_max---0.324--------
Intrinsic Value_1Y_min---0.972--------
Intrinsic Value_3Y_max---1.371--------
Intrinsic Value_3Y_min---3.177--------
Intrinsic Value_5Y_max---2.899--------
Intrinsic Value_5Y_min---5.646--------
Market Cap172523400.000+10%155271060.000235165825.000-34%1185687605.000-87%716177495.000-78%6125303695.000-97%
Net Profit Margin----0%0.327-100%-0.6920%-0.3230%
Operating Margin----0%0.363-100%-0.7490%-0.2600%
Operating Ratio----0%-0.1300%7.020-100%3.883-100%
Pb Ratio1.014+10%0.9121.026-11%3.888-77%3.664-75%57.105-98%
Pe Ratio-1.463-11%-1.316-1.768+34%14.022-109%-10.290+682%-26.532+1916%
Price Per Share2.100+10%1.8902.863-34%14.433-87%8.718-78%5.421-65%
Price To Free Cash Flow Ratio-1.826-11%-1.643-2.338+42%59.903-103%1.665-199%-0.986-40%
Price To Total Gains Ratio-7.041-11%-6.337-8.585+35%39.451-116%-14.701+132%-23.799+276%
Quick Ratio--8.28110.331-20%18.035-54%17.099-52%16.575-50%
Return On Assets---0.142-0.142+0%-0.050-65%-0.086-39%-0.089-37%
Return On Equity---0.173-0.141-18%-0.032-82%-0.082-53%-0.055-68%
Total Gains Per Share---0.298-0.372+25%-0.033-89%0.106-380%-0.003-99%
Usd Book Value--170175000.000217532000.000-22%303586750.000-44%187967050.000-9%219305375.000-22%
Usd Book Value Change Per Share---0.298-0.372+25%-0.033-89%0.103-389%-0.015-95%
Usd Book Value Per Share--2.0712.648-22%3.695-44%2.288-9%2.623-21%
Usd Dividend Per Share----0%-0%0.003-100%0.012-100%
Usd Eps---0.359-0.439+22%-0.212-41%-0.207-42%-0.184-49%
Usd Free Cash Flow---23622000.000-24545250.000+4%-15386750.000-35%-14957350.000-37%-7000075.000-70%
Usd Free Cash Flow Per Share---0.288-0.299+4%-0.187-35%-0.182-37%-0.059-80%
Usd Free Cash Flow To Equity Per Share---0.287-0.298+4%-0.061-79%0.020-1559%0.162-277%
Usd Market Cap172523400.000+10%155271060.000235165825.000-34%1185687605.000-87%716177495.000-78%6125303695.000-97%
Usd Price Per Share2.100+10%1.8902.863-34%14.433-87%8.718-78%5.421-65%
Usd Profit---29489000.000-35351000.000+20%-16715250.000-43%-17884950.000-39%-10327425.000-65%
Usd Revenue----0%-0%9310200.000-100%45656525.000-100%
Usd Total Gains Per Share---0.298-0.372+25%-0.033-89%0.106-380%-0.003-99%
 EOD+5 -3MRQTTM+17 -13YOY+5 -275Y+7 -2710Y+8 -26

4.2. Fundamental Score

Let's check the fundamental score of Adicet Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.463
Price to Book Ratio (EOD)Between0-11.014
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.281
Current Ratio (MRQ)Greater than18.414
Debt to Asset Ratio (MRQ)Less than10.179
Debt to Equity Ratio (MRQ)Less than10.218
Return on Equity (MRQ)Greater than0.15-0.173
Return on Assets (MRQ)Greater than0.05-0.142
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Adicet Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.077
Ma 20Greater thanMa 502.211
Ma 50Greater thanMa 1002.338
Ma 100Greater thanMa 2002.272
OpenGreater thanClose2.140
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets207,295
Total Liabilities37,120
Total Stockholder Equity170,175
 As reported
Total Liabilities 37,120
Total Stockholder Equity+ 170,175
Total Assets = 207,295

Assets

Total Assets207,295
Total Current Assets162,272
Long-term Assets45,023
Total Current Assets
Cash And Cash Equivalents 159,711
Other Current Assets 2,561
Total Current Assets  (as reported)162,272
Total Current Assets  (calculated)162,272
+/-0
Long-term Assets
Property Plant Equipment 44,201
Long-term Assets Other 822
Long-term Assets  (as reported)45,023
Long-term Assets  (calculated)45,023
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities19,287
Long-term Liabilities17,833
Total Stockholder Equity170,175
Total Current Liabilities
Short-term Debt 3,221
Accounts payable 2,625
Other Current Liabilities 13,441
Total Current Liabilities  (as reported)19,287
Total Current Liabilities  (calculated)19,287
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt17,703
Long-term Liabilities Other 130
Long-term Liabilities  (as reported)17,833
Long-term Liabilities  (calculated)17,833
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -380,772
Other Stockholders Equity 550,943
Total Stockholder Equity (as reported)170,175
Total Stockholder Equity (calculated)170,175
+/-0
Other
Capital Stock4
Cash and Short Term Investments 159,711
Common Stock Shares Outstanding 43,035
Liabilities and Stockholders Equity 207,295
Net Debt -138,787
Net Invested Capital 170,175
Net Working Capital 142,985
Property Plant and Equipment Gross 59,048
Short Long Term Debt Total 20,924



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
86,778
88,081
87,937
84,006
123,550
105,173
102,165
109,098
111,455
115,703
115,377
118,628
121,999
123,519
125,904
140,827
145,013
149,697
147,433
155,184
153,522
149,028
151,272
153,057
155,997
166,592
172,185
179,986
184,493
188,478
177,224
185,509
188,933
205,499
194,748
194,664
184,178
189,274
186,953
198,051
208,796
216,556
213,758
289,539
286,449
294,993
292,355
300,673
309,804
299,280
300,044
315,447
333,282
323,430
333,262
339,762
349,862
467,984
460,764
479,800
481,621
489,774
490,646
524,394
544,600
540,778
544,695
1,044,714
1,058,620
1,038,185
1,017,973
55,193
137,245
128,780
117,426
109,939
145,080
136,658
121,963
81,587
78,206
74,342
150,397
153,835
282,073
268,778
257,195
338,938
340,451
329,904
354,303
330,690
304,974
277,633
233,257
207,295
207,295233,257277,633304,974330,690354,303329,904340,451338,938257,195268,778282,073153,835150,39774,34278,20681,587121,963136,658145,080109,939117,426128,780137,24555,1931,017,9731,038,1851,058,6201,044,714544,695540,778544,600524,394490,646489,774481,621479,800460,764467,984349,862339,762333,262323,430333,282315,447300,044299,280309,804300,673292,355294,993286,449289,539213,758216,556208,796198,051186,953189,274184,178194,664194,748205,499188,933185,509177,224188,478184,493179,986172,185166,592155,997153,057151,272149,028153,522155,184147,433149,697145,013140,827125,904123,519121,999118,628115,377115,703111,455109,098102,165105,173123,55084,00687,93788,08186,778
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
165,362
173,512
177,057
193,784
183,299
183,688
173,341
171,646
169,595
181,242
186,743
195,553
192,911
192,558
188,112
198,615
180,425
189,674
201,018
191,969
193,602
209,489
228,486
218,300
228,887
235,868
246,909
276,354
271,212
291,137
295,547
310,310
307,399
329,177
351,274
352,661
356,057
459,220
480,951
471,555
467,700
55,154
136,845
128,372
117,023
109,534
144,678
136,088
121,281
64,186
77,581
73,749
117,411
94,614
229,106
216,303
199,025
282,438
281,532
264,088
285,737
261,038
234,808
208,656
185,883
162,272
162,272185,883208,656234,808261,038285,737264,088281,532282,438199,025216,303229,10694,614117,41173,74977,58164,186121,281136,088144,678109,534117,023128,372136,84555,154467,700471,555480,951459,220356,057352,661351,274329,177307,399310,310295,547291,137271,212276,354246,909235,868228,887218,300228,486209,489193,602191,969201,018189,674180,425198,615188,112192,558192,911195,553186,743181,242169,595171,646173,341183,688183,299193,784177,057173,512165,362000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
7,310
0
0
0
14,255
0
0
0
20,263
0
0
0
32,330
0
0
0
19,950
0
0
0
33,732
36,261
30,608
31,774
32,320
37,416
39,030
32,239
46,515
32,475
25,504
39,263
57,761
50,732
46,971
38,298
30,850
40,113
24,805
20,984
28,664
32,186
28,242
26,611
24,862
24,343
25,326
35,423
33,231
35,058
41,967
34,383
42,897
40,669
37,216
33,709
34,020
30,830
54,349
53,093
66,828
73,142
68,008
59,962
55,680
72,100
53,349
135,705
51,353
22,856
7,042
7,181
21,371
23,621
10,607
61,232
70,889
84,960
84,330
221,667
208,726
192,226
277,544
277,883
260,642
282,679
257,656
231,640
205,460
183,257
159,711
159,711183,257205,460231,640257,656282,679260,642277,883277,544192,226208,726221,66784,33084,96070,88961,23210,60723,62121,3717,1817,04222,85651,353135,70553,34972,10055,68059,96268,00873,14266,82853,09354,34930,83034,02033,70937,21640,66942,89734,38341,96735,05833,23135,42325,32624,34324,86226,61128,24232,18628,66420,98424,80540,11330,85038,29846,97150,73257,76139,26325,50432,47546,51532,23939,03037,41632,32031,77430,60836,26133,73200019,95000032,33000020,26300014,2550007,31000000
       Short-term Investments 
0
0
0
0
0
988
0
0
0
1,320
0
0
0
877
0
0
0
888
0
0
0
5,068
0
0
0
3,309
5,347
9,632
6,394
3,036
3,098
3,125
1,169
548
10,875
10,728
487
541
590
615
608
335
402
446
487
943
844
458
1,539
1,518
581
1,549
1,655
2,144
2,165
1,693
1,744
746
1,805
1,799
1,834
3,416
2,392
2,396
2,394
881
1,910
1,911
1,966
2,046
3,048
3,054
3,059
74,570
92,522
100,986
135,910
111,425
93,641
51,793
15,111
0
23,160
10,284
1,753
0
0
0
0
0
0
0
0
0
0
0
000000000001,75310,28423,160015,11151,79393,641111,425135,910100,98692,52274,5703,0593,0543,0482,0461,9661,9111,9108812,3942,3962,3923,4161,8341,7991,8057461,7441,6932,1652,1441,6551,5495811,5181,53945884494348744640233560861559054148710,72810,8755481,1693,1253,0983,0366,3949,6325,3473,3090005,0680008880008770001,32000098800000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
74,674
58,354
63,663
0
83,735
65,925
76,567
84,381
74,744
76,795
77,918
95,904
90,108
93,197
87,966
100,624
122,694
126,455
148,004
149,766
161,521
167,925
152,196
176,777
167,612
158,744
224,408
260,530
260,889
240,620
241,971
260,168
247,246
292,378
262,325
0
0
0
935
935
13,489
3,467
2,731
2,791
2,712
2,711
214
0
0
288
435
567
639
20
0
020639567435288002142,7112,7122,7912,7313,46713,489935935000262,325292,378247,246260,168241,971240,620260,889260,530224,408158,744167,612176,777152,196167,925161,521149,766148,004126,455122,694100,62487,96693,19790,10895,90477,91876,79574,74484,38176,56765,92583,735063,66358,35474,67400000000000000000000000000000000000000000
       Other Current Assets 
2,013
2,514
2,412
2,538
2,616
2,942
3,013
2,973
3,035
2,195
1,994
2,112
1,922
1,642
1,937
1,558
1,440
2,778
3,287
5,754
5,636
3,843
4,375
4,299
4,259
4,407
4,757
4,736
4,521
3,669
65,089
65,821
80,317
75,612
71,454
70,014
70,019
58,942
63,940
63,880
78,429
14,837
16,992
14,964
89,319
7,840
6,567
5,576
5,859
6,158
6,183
7,323
8,823
8,968
11,201
9,591
10,613
9,334
10,104
11,010
13,022
15,757
15,950
14,661
18,696
19,233
17,805
20,260
18,552
16,553
4,916
1,805
1,140
2,449
1,645
1,506
1,587
3,292
4,019
179
1,238
2,860
55
363
124
373
1
2
3,649
3,446
3,029
380
511
489
378
2,561
2,5613784895113803,0293,4463,64921373124363552,8601,2381794,0193,2921,5871,5061,6452,4491,1401,8054,91616,55318,55220,26017,80519,23318,69614,66115,95015,75713,02211,01010,1049,33410,6139,59111,2018,9688,8237,3236,1836,1585,8595,5766,5677,84089,31914,96416,99214,83778,42963,88063,94058,94270,01970,01471,45475,61280,31765,82165,0893,6694,5214,7364,7574,4074,2594,2994,3753,8435,6365,7543,2872,7781,4401,5581,9371,6421,9222,1121,9942,1953,0352,9733,0132,9422,6162,5382,4122,5142,013
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,862
11,997
11,876
11,715
11,449
10,976
10,837
17,628
17,358
16,809
22,053
21,003
20,847
96,981
98,337
96,378
111,930
110,999
108,786
107,311
106,442
105,958
104,796
105,130
104,375
103,894
102,953
191,630
189,552
188,663
186,074
179,464
183,247
195,217
193,326
188,117
188,638
585,494
577,669
566,630
550,273
39
400
408
403
405
402
570
682
17,401
625
593
32,986
59,221
52,967
52,475
58,170
56,500
58,919
65,816
68,566
69,652
70,166
68,977
47,374
45,023
45,02347,37468,97770,16669,65268,56665,81658,91956,50058,17052,47552,96759,22132,98659362517,40168257040240540340840039550,273566,630577,669585,494188,638188,117193,326195,217183,247179,464186,074188,663189,552191,630102,953103,894104,375105,130104,796105,958106,442107,311108,786110,999111,93096,37898,33796,98120,84721,00322,05316,80917,35817,62810,83710,97611,44911,71511,87611,99711,862000000000000000000000000000000
       Property Plant Equipment 
890
1,289
1,655
1,584
2,052
2,539
2,611
2,492
2,394
2,432
2,438
2,421
2,321
2,275
2,276
2,640
2,585
2,654
2,867
5,078
5,374
5,543
5,479
5,399
5,237
4,808
4,718
4,594
4,426
4,406
4,235
4,473
4,308
4,307
4,559
4,378
4,213
4,249
4,184
4,086
7,055
6,913
7,183
9,073
11,914
12,095
11,809
11,857
11,717
11,705
11,755
11,848
11,631
11,410
11,449
11,443
11,151
11,573
11,265
11,136
10,775
10,456
10,357
10,376
10,151
10,044
10,216
9,919
10,289
10,428
11,569
39
316
324
319
321
318
325
437
2,121
380
348
2,043
25,856
25,502
26,484
32,260
35,001
37,449
44,565
47,823
48,979
49,594
48,510
46,458
44,201
44,20146,45848,51049,59448,97947,82344,56537,44935,00132,26026,48425,50225,8562,0433483802,1214373253183213193243163911,56910,42810,2899,91910,21610,04410,15110,37610,35710,45610,77511,13611,26511,57311,15111,44311,44911,41011,63111,84811,75511,70511,71711,85711,80912,09511,9149,0737,1836,9137,0554,0864,1844,2494,2134,3784,5594,3074,3084,4734,2354,4064,4264,5944,7184,8085,2375,3995,4795,5435,3745,0782,8672,6542,5852,6402,2762,2752,3212,4212,4382,4322,3942,4922,6112,5392,0521,5841,6551,289890
       Goodwill 
0
0
0
0
0
10,367
0
0
9,969
9,821
9,821
7,948
7,948
7,783
7,716
10,766
7,949
3,179
3,197
2,347
2,295
1,720
1,720
1,703
1,721
1,755
1,765
1,802
1,812
1,820
1,877
1,910
1,987
1,987
1,890
1,865
1,801
1,861
1,901
1,882
1,819
1,730
1,830
33,543
33,604
33,625
33,568
33,522
33,549
33,495
33,515
33,541
33,512
33,526
33,563
33,804
33,804
66,516
66,432
67,963
67,848
67,870
67,883
67,853
67,893
67,871
67,880
241,402
241,741
236,970
237,004
237,019
1,939
1,883
1,876
1,862
0
0
0
0
0
0
20,739
20,089
19,863
19,462
19,462
19,462
19,462
19,462
19,462
19,462
19,462
19,462
0
0
0019,46219,46219,46219,46219,46219,46219,46219,46219,46219,86320,08920,7390000001,8621,8761,8831,939237,019237,004236,970241,741241,40267,88067,87167,89367,85367,88367,87067,84867,96366,43266,51633,80433,80433,56333,52633,51233,54133,51533,49533,54933,52233,56833,62533,60433,5431,8301,7301,8191,8821,9011,8611,8011,8651,8901,9871,9871,9101,8771,8201,8121,8021,7651,7551,7211,7031,7201,7202,2952,3473,1973,1797,94910,7667,7167,7837,9487,9489,8219,8219,9690010,36700000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
401
1,539
1,839
2,051
1,135
0
0
0
10,588
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000010,5880001,1352,0511,8391,53940100000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
10,367
0
0
9,969
10,522
9,821
7,948
8,968
8,195
7,716
10,766
10,984
6,880
6,831
6,199
5,807
4,873
4,879
5,501
5,419
5,544
5,496
5,852
5,776
7,637
5,750
5,614
5,581
5,421
5,000
4,733
4,823
11,518
11,273
10,841
13,179
12,360
11,834
54,365
52,819
50,658
49,190
48,107
46,698
45,251
43,830
42,475
41,296
40,831
39,426
38,894
37,621
87,955
86,215
83,614
81,463
78,997
82,745
83,387
81,647
79,071
77,884
300,567
292,788
285,081
277,247
270,072
241,513
234,602
227,738
221,039
0
0
0
0
0
0
3,490
1,190
730
0
0
0
0
0
0
0
0
0
0
0
000000000007301,1903,490000000221,039227,738234,602241,513270,072277,247285,081292,788300,56777,88479,07181,64783,38782,74578,99781,46383,61486,21587,95537,62138,89439,42640,83141,29642,47543,83045,25146,69848,10749,19050,65852,81954,36511,83412,36013,17910,84111,27311,5184,8234,7335,0005,4215,5815,6145,7507,6375,7765,8525,4965,5445,4195,5014,8794,8735,8076,1996,8316,88010,98410,7667,7168,1958,9687,9489,82110,5229,9690010,36700000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,886
13,833
14,054
12,141
12,601
13,399
13,673
11,308
11,880
11,647
12,316
13,981
13,940
14,185
14,470
12,169
12,316
13,069
13,971
13,078
15,064
16,446
16,196
14,698
13,462
14,748
84
84
84
84
84
245
245
4,692
245
245
6,714
12,086
6,872
6,529
6,448
2,037
2,008
1,789
1,281
1,211
1,110
1,005
916
822
8229161,0051,1101,2111,2811,7892,0082,0376,4486,5296,87212,0866,7142452454,692245245848484848414,74813,46214,69816,19616,44615,06413,07813,97113,06912,31612,16914,47014,18513,94013,98112,31611,64711,88011,30813,67313,39912,60112,14114,05413,83313,8860000000000000000000000000000000000000000000000
> Total Liabilities 
22,882
24,477
23,337
20,212
52,597
35,970
32,030
38,869
39,759
42,413
39,828
42,625
43,112
38,950
37,522
47,622
47,421
49,274
43,041
48,299
45,335
41,202
41,341
44,067
43,458
51,307
53,785
60,007
62,094
63,349
62,526
70,492
69,457
81,834
67,860
68,949
58,875
63,896
58,572
74,295
84,403
92,207
81,781
153,859
144,775
150,844
130,983
139,102
141,155
131,277
126,417
136,186
148,113
128,790
124,824
121,740
126,455
234,400
225,777
241,135
241,274
235,563
225,471
238,537
245,749
236,336
234,872
648,419
656,469
633,118
608,743
5,502
6,862
11,616
8,086
5,735
4,624
9,717
12,199
141,953
2,589
3,598
33,467
44,008
45,814
40,437
39,971
35,809
29,367
36,637
36,645
38,352
38,759
38,572
38,580
37,120
37,12038,58038,57238,75938,35236,64536,63729,36735,80939,97140,43745,81444,00833,4673,5982,589141,95312,1999,7174,6245,7358,08611,6166,8625,502608,743633,118656,469648,419234,872236,336245,749238,537225,471235,563241,274241,135225,777234,400126,455121,740124,824128,790148,113136,186126,417131,277141,155139,102130,983150,844144,775153,85981,78192,20784,40374,29558,57263,89658,87568,94967,86081,83469,45770,49262,52663,34962,09460,00753,78551,30743,45844,06741,34141,20245,33548,29943,04149,27447,42147,62237,52238,95043,11242,62539,82842,41339,75938,86932,03035,97052,59720,21223,33724,47722,882
   > Total Current Liabilities 
21,974
23,569
22,654
19,695
51,409
35,299
31,533
38,693
39,697
42,413
39,828
42,625
43,112
38,950
37,522
47,622
47,421
48,845
40,293
45,585
42,184
37,391
37,390
39,333
38,582
36,399
39,061
45,052
47,235
48,103
47,110
54,898
53,489
64,998
52,070
53,227
43,340
46,937
42,573
58,565
66,874
74,629
64,338
85,907
77,884
83,186
64,567
73,836
79,450
73,641
66,900
78,152
91,160
89,907
89,667
89,973
100,121
118,523
110,251
126,444
128,143
125,000
105,160
102,594
110,341
98,906
93,197
207,626
232,073
222,805
227,149
5,502
6,834
11,591
8,064
5,716
4,609
9,706
12,193
14,865
2,565
3,564
30,077
13,980
25,183
20,947
20,032
16,317
10,401
16,398
17,221
19,707
18,095
18,839
19,768
19,287
19,28719,76818,83918,09519,70717,22116,39810,40116,31720,03220,94725,18313,98030,0773,5642,56514,86512,1939,7064,6095,7168,06411,5916,8345,502227,149222,805232,073207,62693,19798,906110,341102,594105,160125,000128,143126,444110,251118,523100,12189,97389,66789,90791,16078,15266,90073,64179,45073,83664,56783,18677,88485,90764,33874,62966,87458,56542,57346,93743,34053,22752,07064,99853,48954,89847,11048,10347,23545,05239,06136,39938,58239,33337,39037,39142,18445,58540,29348,84547,42147,62237,52238,95043,11242,62539,82842,41339,69738,69331,53335,29951,40919,69522,65423,56921,974
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,197
6,197
6,447
6,713
6,964
7,197
7,464
11,714
7,947
8,197
9,447
8,343
8,697
9,197
9,697
10,197
197
197
197
197
197
14,466
14,466
14,466
14,482
14,482
190,723
14,482
14,482
183,772
0
0
0
0
0
0
23,160
1,215
1,247
1,051
712
1,567
1,733
2,261
2,409
2,492
2,949
3,039
3,128
3,221
3,2213,1283,0392,9492,4922,4092,2611,7331,5677121,0511,2471,21523,160000000183,77214,48214,482190,72314,48214,48214,46614,46614,46619719719719719710,1979,6979,1978,6978,3439,4478,1977,94711,7147,4647,1976,9646,7136,4476,1976,1970000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
105,938
0
0
0
10,197
0
0
0
197
197
14,466
14,466
14,466
14,482
14,482
190,723
14,482
14,482
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000014,48214,482190,72314,48214,48214,46614,46614,46619719700010,197000105,938000000000000000000000000000000000000000000000000000000000
       Accounts payable 
2,790
3,252
3,448
3,505
9,809
12,062
9,278
10,764
13,929
18,399
16,812
16,003
17,680
18,687
17,312
23,170
20,299
27,784
29,345
30,090
29,796
27,245
27,186
25,988
25,881
24,424
24,500
30,102
33,123
32,539
28,796
34,638
35,061
43,480
30,572
32,069
25,397
25,126
22,630
34,432
36,091
39,970
30,135
35,535
37,338
44,614
32,998
38,783
47,078
42,007
37,988
43,982
50,220
39,222
41,588
40,066
48,278
48,716
43,586
49,086
55,836
54,962
49,280
57,441
60,860
46,034
49,271
89,933
111,364
90,011
98,013
106,735
125,083
106,790
123,384
0
3,364
8,242
9,973
1,052
1,210
2,467
3,838
1,552
1,748
2,316
4,631
3,263
3,465
4,146
4,570
4,404
2,747
3,121
4,066
2,625
2,6254,0663,1212,7474,4044,5704,1463,4653,2634,6312,3161,7481,5523,8382,4671,2101,0529,9738,2423,3640123,384106,790125,083106,73598,01390,011111,36489,93349,27146,03460,86057,44149,28054,96255,83649,08643,58648,71648,27840,06641,58839,22250,22043,98237,98842,00747,07838,78332,99844,61437,33835,53530,13539,97036,09134,43222,63025,12625,39732,06930,57243,48035,06134,63828,79632,53933,12330,10224,50024,42425,88125,98827,18627,24529,79630,09029,34527,78420,29923,17017,31218,68717,68016,00316,81218,39913,92910,7649,27812,0629,8093,5053,4483,2522,790
       Other Current Liabilities 
17,039
18,528
16,809
14,289
17,118
11,144
13,280
18,060
16,838
14,824
13,964
18,483
17,789
16,977
17,433
21,989
25,087
20,061
9,677
14,995
11,888
9,095
9,704
12,845
12,184
9,456
11,753
13,793
12,925
13,535
15,750
17,579
15,702
19,762
19,862
19,479
16,146
20,232
18,342
22,481
29,247
32,795
32,453
48,934
39,240
37,825
24,855
28,454
25,299
24,863
20,950
25,946
32,216
38,270
39,406
40,825
41,464
60,974
57,536
67,235
61,249
57,791
54,102
42,803
46,773
49,431
41,886
100,715
103,648
117,782
114,654
5,502
6,834
11,591
8,064
5,716
1,245
1,464
2,220
2,820
1,355
1,097
6,849
-2,767
4,227
4,433
4,601
6,682
5,203
9,991
10,242
12,811
12,399
12,679
12,574
13,441
13,44112,57412,67912,39912,81110,2429,9915,2036,6824,6014,4334,227-2,7676,8491,0971,3552,8202,2201,4641,2455,7168,06411,5916,8345,502114,654117,782103,648100,71541,88649,43146,77342,80354,10257,79161,24967,23557,53660,97441,46440,82539,40638,27032,21625,94620,95024,86325,29928,45424,85537,82539,24048,93432,45332,79529,24722,48118,34220,23216,14619,47919,86219,76215,70217,57915,75013,53512,92513,79311,7539,45612,18412,8459,7049,09511,88814,9959,67720,06125,08721,98917,43316,97717,78918,48313,96414,82416,83818,06013,28011,14417,11814,28916,80918,52817,039
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,929
18,875
17,043
19,948
18,420
0
16,865
20,739
18,871
23,062
29,711
33,589
28,306
43,693
6,000
6,247
60,605
59,512
56,017
52,003
54,258
52,938
50,583
33,774
30,542
27,448
22,369
108,798
109,949
109,317
107,921
107,568
117,633
133,456
133,172
134,078
135,303
435,781
421,388
407,974
379,840
377,676
28
25
22
19
15
11
6
127,088
24
34
3,390
246,180
20,631
19,490
19,939
19,492
18,966
20,239
19,424
18,645
20,664
19,733
18,812
17,833
17,83318,81219,73320,66418,64519,42420,23918,96619,49219,93919,49020,631246,1803,3903424127,0886111519222528377,676379,840407,974421,388435,781135,303134,078133,172133,456117,633107,568107,921109,317109,949108,79822,36927,44830,54233,77450,58352,93854,25852,00356,01759,51260,6056,2476,00043,69328,30633,58929,71123,06218,87120,73916,865018,42019,94817,04318,87516,929000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
429
2,748
2,714
3,151
3,811
3,951
4,734
4,876
11,579
11,571
11,729
11,762
12,500
12,504
12,613
12,776
14,612
14,479
14,574
14,627
15,996
15,547
15,213
17,276
17,028
16,849
23,356
23,371
18,857
19,171
19,590
17,824
18,576
18,247
17,571
20,529
18,522
16,832
15,502
13,371
18,713
15,869
15,597
15,615
10,537
10,368
9,823
8,601
9,696
13,023
64,112
63,310
63,788
64,497
67,298
64,006
66,305
66,021
0
0
0
0
0
7,200
4,610
3,390
1,105
677
0
116
115
115
115
116
114
0
130
143
0
0143130011411611511511511606771,1053,3904,6107,2000000066,02166,30564,00667,29864,49763,78863,31064,11213,0239,6968,6019,82310,36810,53715,61515,59715,86918,71313,37115,50216,83218,52220,52917,57118,24718,57617,82419,59019,17118,85723,37123,35616,84917,02817,27615,21315,54715,99614,62714,57414,47914,61212,77612,61312,50412,50011,76211,72911,57111,5794,8764,7343,9513,8113,1512,7142,74842900000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
300
200
200
200
100
100
100
0
0
0
0
0
0
0
0
0000000010010010020020020030030000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
63,896
63,604
64,600
63,794
70,953
69,203
70,135
70,229
71,696
73,290
75,549
76,003
78,887
84,569
88,382
93,205
97,592
100,266
104,239
106,754
107,972
107,655
109,753
108,833
112,364
115,053
118,161
119,725
122,154
124,827
128,716
129,185
133,959
140,409
141,363
140,172
139,555
141,568
144,746
140,750
141,991
139,644
147,880
152,279
159,071
160,821
161,372
161,571
168,649
168,003
173,627
179,261
185,169
194,640
208,438
218,022
223,407
233,584
234,987
238,665
240,347
254,211
265,175
285,857
298,851
304,442
309,823
396,295
402,151
405,067
409,230
-31,929
130,383
117,164
109,340
104,204
140,456
126,941
109,764
-60,366
75,617
70,744
116,930
109,827
236,259
228,341
217,224
-168,324
311,084
293,267
317,658
-238,114
-268,995
239,061
194,677
170,175
170,175194,677239,061-268,995-238,114317,658293,267311,084-168,324217,224228,341236,259109,827116,93070,74475,617-60,366109,764126,941140,456104,204109,340117,164130,383-31,929409,230405,067402,151396,295309,823304,442298,851285,857265,175254,211240,347238,665234,987233,584223,407218,022208,438194,640185,169179,261173,627168,003168,649161,571161,372160,821159,071152,279147,880139,644141,991140,750144,746141,568139,555140,172141,363140,409133,959129,185128,716124,827122,154119,725118,161115,053112,364108,833109,753107,655107,972106,754104,239100,26697,59293,20588,38284,56978,88776,00375,54973,29071,69670,22970,13569,20370,95363,79464,60063,60463,896
   Common Stock
90
90
90
90
90
90
90
90
90
90
90
82
123
123
123
123
176
176
176
171
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
256
266
266
266
267
268
268
269
272
273
274
278
281
284
285
288
291
291
291
292
295
296
296
296
300
301
301
301
306
1
3
3
3
3
4
4
4
4
4
4
1
2
3
3
3
4
4
4
4
4
4
4
4
4
4444444443332144444433331306301301301300296296296295292291291291288285284281278274273272269268268267266266266256256256256256256256256256256256256256256256256256256256256256256256171176176176123123123123829090909090909090909090
   Retained Earnings 
34,885
35,697
36,626
36,876
38,830
37,242
38,100
38,022
39,441
40,958
43,179
42,985
45,534
47,182
50,370
52,799
56,380
58,034
61,820
63,371
64,407
64,001
66,025
65,585
68,842
71,304
74,255
75,545
77,869
80,410
75,713
74,178
76,248
81,778
86,330
84,945
86,880
85,450
86,454
81,423
85,264
86,958
89,755
86,021
89,878
90,713
93,746
95,665
101,044
102,344
105,677
108,680
114,758
118,615
128,263
133,304
136,951
140,768
143,837
148,694
155,325
167,208
174,745
181,215
189,849
194,804
197,235
194,509
198,139
195,680
194,171
-33,779
-43,638
-57,229
-65,636
-71,393
-82,462
-100,794
-125,242
-69,647
-161,170
-166,769
-97,367
-106,325
-127,644
-138,498
-152,511
-168,324
-163,706
-186,244
-208,240
-238,114
-268,995
-301,398
-351,283
-380,772
-380,772-351,283-301,398-268,995-238,114-208,240-186,244-163,706-168,324-152,511-138,498-127,644-106,325-97,367-166,769-161,170-69,647-125,242-100,794-82,462-71,393-65,636-57,229-43,638-33,779194,171195,680198,139194,509197,235194,804189,849181,215174,745167,208155,325148,694143,837140,768136,951133,304128,263118,615114,758108,680105,677102,344101,04495,66593,74690,71389,87886,02189,75586,95885,26481,42386,45485,45086,88084,94586,33081,77876,24874,17875,71380,41077,86975,54574,25571,30468,84265,58566,02564,00164,40763,37161,82058,03456,38052,79950,37047,18245,53442,98543,17940,95839,44138,02238,10037,24238,83036,87636,62635,69734,885
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
235,777
236,751
237,509
214,213
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000214,213237,509236,751235,7770000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000-230-238-650-1,926-2,209-2,929-3,480-8,355-8,430-8,482-8,829-10,767-11,571-11,684-11,710-12,542-12,693-12,765-12,895-13,114-13,198-13,403-13,735-13,368-13,505-13,848-14,118-14,927-15,135-16,088-17,048-19,258-19,836-23,311-23,769-24,235-24,252-24,319-24,366-24,515-24,545-24,342-30,280-29,170-29,237-28,133
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,343
44,917
44,930
45,261
46,072
47,316
47,949
48,337
48,686
50,557
50,973
51,477
51,850
61,309
61,871
62,099
62,448
62,839
63,210
64,071
65,322
66,625
67,885
72,845
74,911
78,304
80,079
87,156
89,710
91,112
92,329
93,807
96,314
111,630
113,793
115,667
118,053
210,958
212,486
214,198
-2,686
1,849
174,018
45,640
57,623
175,594
222,882
227,561
234,893
9,258
236,751
237,509
63,816
216,126
363,898
366,836
369,732
-4
474,786
479,507
525,894
-4
-4
540,455
545,956
550,943
550,943545,956540,455-4-4525,894479,507474,786-4369,732366,836363,898216,12663,816237,509236,7519,258234,893227,561222,882175,59457,62345,640174,0181,849-2,686214,198212,486210,958118,053115,667113,793111,63096,31493,80792,32991,11289,71087,15680,07978,30474,91172,84567,88566,62565,32264,07163,21062,83962,44862,09961,87161,30951,85051,47750,97350,55748,68648,33747,94947,31646,07245,26144,93044,91744,343000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-6,098
Gross Profit-6,098-6,098
 
Operating Income (+$)
Gross Profit-6,098
Operating Expense-126,478
Operating Income-132,576-132,576
 
Operating Expense (+$)
Research Development106,043
Selling General Administrative26,533
Selling And Marketing Expenses6,098
Operating Expense126,478138,674
 
Net Interest Income (+$)
Interest Income9,978
Interest Expense-25
Other Finance Cost-0
Net Interest Income9,953
 
Pretax Income (+$)
Operating Income-132,576
Net Interest Income9,953
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-142,658-122,494
EBIT - interestExpense = -132,601
-142,658
-142,633
Interest Expense25
Earnings Before Interest and Taxes (EBIT)-132,576-142,633
Earnings Before Interest and Taxes (EBITDA)-126,478
 
After tax Income (+$)
Income Before Tax-142,658
Tax Provision-0
Net Income From Continuing Ops-142,658-142,658
Net Income-142,658
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses132,576
Total Other Income/Expenses Net-10,082-9,953
 

Technical Analysis of Adicet Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Adicet Bio Inc. The general trend of Adicet Bio Inc is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Adicet Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Adicet Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.13 < 2.43 < 3.59.

The bearish price targets are: 1.88 > 1.851 > 1.69.

Tweet this
Adicet Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Adicet Bio Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Adicet Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Adicet Bio Inc. The current macd is -0.07218065.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Adicet Bio Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Adicet Bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Adicet Bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Adicet Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartAdicet Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Adicet Bio Inc. The current adx is 10.05.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Adicet Bio Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Adicet Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Adicet Bio Inc. The current sar is 2.32423633.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Adicet Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Adicet Bio Inc. The current rsi is 45.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Adicet Bio Inc Daily Relative Strength Index (RSI) ChartAdicet Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Adicet Bio Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Adicet Bio Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Adicet Bio Inc Daily Stochastic Oscillator ChartAdicet Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Adicet Bio Inc. The current cci is -60.2747013.

Adicet Bio Inc Daily Commodity Channel Index (CCI) ChartAdicet Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Adicet Bio Inc. The current cmo is -8.49995191.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Adicet Bio Inc Daily Chande Momentum Oscillator (CMO) ChartAdicet Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Adicet Bio Inc. The current willr is -60.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Adicet Bio Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Adicet Bio Inc Daily Williams %R ChartAdicet Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Adicet Bio Inc.

Adicet Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Adicet Bio Inc. The current atr is 0.15867327.

Adicet Bio Inc Daily Average True Range (ATR) ChartAdicet Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Adicet Bio Inc. The current obv is -6,343,682.

Adicet Bio Inc Daily On-Balance Volume (OBV) ChartAdicet Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Adicet Bio Inc. The current mfi is 56.69.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Adicet Bio Inc Daily Money Flow Index (MFI) ChartAdicet Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Adicet Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-31MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Adicet Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Adicet Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.077
Ma 20Greater thanMa 502.211
Ma 50Greater thanMa 1002.338
Ma 100Greater thanMa 2002.272
OpenGreater thanClose2.140
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Adicet Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Adicet Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Adicet Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Adicet Bio Inc

I send you an email if I find something interesting about Adicet Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Adicet Bio Inc.

Receive notifications about Adicet Bio Inc in your mailbox!